ADVERTISEMENT

Mindtree Q4 net up 8.9% at ₹198.4 cr; board declares special dividend of 200%

April 17, 2019 03:44 pm | Updated 03:44 pm IST - New Delhi

Mindtree is facing an hostile takeover bid by infrastructure giant L&T.

Mid-sized IT firm Mindtree on Wednesday said its consolidated net profit grew 8.9% to ₹198.4 crore for the March 2019 quarter, from ₹182.2 crore in the year-ago period.

The Bengaluru-based company’s revenue also increased by 25.6% to ₹1,839.4 crore in the said quarter, as compared to ₹1,464 crore in the year-ago period, Mindtree said in a regulatory filing.

Mindtree, which is facing an hostile takeover bid by infrastructure giant L&T, said its board has also declared an interim dividend of ₹3 per equity share, and recommended a special dividend of 200% (₹20 a share) to “celebrate the twin achievements of exceeding $1 billion annual revenue milestone and 20th anniversary of the company” subject to shareholders’ nod.

ADVERTISEMENT

“Mindtree has delivered exceptional performance for both the fourth quarter and the full fiscal year as we cross the historic $1 billion milestone. Over the course of two decades our strategy of being expertise-led and backed by a unique culture continues to help us attract world-class people and create customer successes,” Mindtree CEO and managing director Rostow Ravanan said.

He added that the company is “well-poised to continue delivering industry leading returns for all our stakeholders, the best is yet to come”.

Mindtree’s FY’19 net profit grew 32.2% to ₹754.1 crore, while revenue was up 28.5% to ₹7,021.5 crore from the previous fiscal.

ADVERTISEMENT

This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
This is your last free article.

ADVERTISEMENT

ADVERTISEMENT